Nuvigil Gets Protection Until 2023 Under New Patent
This article was originally published in The Pink Sheet Daily
Executive Summary
Composition-of-matter claim for “enantiomers of modafinil” adds a decade to the patent life of Cephalon’s follow-on wakefulness treatment.